Starpharma Holdings (ASX:SPL) Preferred Dividends : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Starpharma Holdings Preferred Dividends?

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Starpharma Holdings's preferred dividends for the six months ended in Dec. 2024 was A$0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Starpharma Holdings Preferred Dividends Historical Data

The historical data trend for Starpharma Holdings's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Preferred Dividends Chart

Starpharma Holdings Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Preferred Dividends

Get a 7-Day Free Trial

Starpharma Holdings Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Preferred Dividends	Get a 7-Day Free Trial															-	-	-	-	-

Starpharma Holdings Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Starpharma Holdings (ASX:SPL) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Starpharma Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (ASX:SPL) » Definitions » Preferred Dividends

Comparable Companies

Traded in Other Exchanges

SPHRY:USA SPHRF:USA PQ6:Germany

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.

Starpharma Holdings Headlines

No Headlines